BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9217564)

  • 1. Myocardial infarction in newly diagnosed hypertensive Medicaid patients free of coronary heart disease and treated with calcium channel blockers.
    Leader SG; Mallick R; Briggs NC
    Am J Med; 1997 Feb; 102(2):150-7. PubMed ID: 9217564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers.
    Bakris GL; Cooper-Dehoff RM; Zhou Q; Kupfer S; Champion A; Pepine CJ;
    Am J Cardiovasc Drugs; 2007; 7 Suppl 1():25-9. PubMed ID: 19845074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diuretic or Beta-Blocker for Hypertensive Patients Already Receiving ACEI/ARB and Calcium Channel Blocker.
    Tsai MS; Tang CH; Lin CY; Chuang PY; Chen NC; Huang CH; Chang WT; Wang TD; Yu PH; Chen WJ
    Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):535-543. PubMed ID: 29218625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blockers for hypertension.
    Wiysonge CS; Bradley H; Mayosi BM; Maroney R; Mbewu A; Opie LH; Volmink J
    Cochrane Database Syst Rev; 2007 Jan; (1):CD002003. PubMed ID: 17253471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Calcium Channel Blockers Versus Other Classes of Antihypertensive Medication in the Treatment of Hypertensive Patients With Previous Stroke and/or Coronary Artery Disease: A Systematic Review and Meta-Analysis.
    Jeffers BW; Robbins J; Bhambri R
    Am J Ther; 2017; 24(1):e68-e80. PubMed ID: 26588586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial infarction and stroke associated with diuretic based two drug antihypertensive regimens: population based case-control study.
    Boger-Megiddo I; Heckbert SR; Weiss NS; McKnight B; Furberg CD; Wiggins KL; Delaney JA; Siscovick DS; Larson EB; Lemaitre RN; Smith NL; Rice KM; Glazer NL; Psaty BM
    BMJ; 2010 Jan; 340():c103. PubMed ID: 20100777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnitude of and Characteristics Associated With the Treatment of Calcium Channel Blocker-Induced Lower-Extremity Edema With Loop Diuretics.
    Vouri SM; Jiang X; Manini TM; Solberg LM; Pepine C; Malone DC; Winterstein AG
    JAMA Netw Open; 2019 Dec; 2(12):e1918425. PubMed ID: 31880802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence-based evaluation of calcium channel blockers for hypertension: equality of mortality and cardiovascular risk relative to conventional therapy.
    Opie LH; Schall R
    J Am Coll Cardiol; 2002 Jan; 39(2):315-22. PubMed ID: 11788225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of myocardial infarction associated with antihypertensive drug therapies.
    Psaty BM; Heckbert SR; Koepsell TD; Siscovick DS; Raghunathan TE; Weiss NS; Rosendaal FR; Lemaitre RN; Smith NL; Wahl PW
    JAMA; 1995 Aug 23-30; 274(8):620-5. PubMed ID: 7637142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The calcium channel blocker controversy in perspective.
    Zanchetti A
    Cardiology; 1997; 88 Suppl 1():66-70; discussion 71-2. PubMed ID: 9118170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension: A Systematic Review and Meta-Analysis of 18 Prospective, Randomized, Actively Controlled Trials.
    Chaugai S; Sherpa LY; Sepehry AA; Kerman SRJ; Arima H
    J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):433-445. PubMed ID: 29739234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium channel blockers in hypertension: reappraisal after new trials and major meta-analyses.
    Opie LH
    Am J Hypertens; 2001 Oct; 14(10):1074-81. PubMed ID: 11710789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival prospects after acute myocardial infarction in the UK: a matched cohort study 1987-2011.
    Gitsels LA; Kulinskaya E; Steel N
    BMJ Open; 2017 Jan; 7(1):e013570. PubMed ID: 28119386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a Common Prescribing Cascade of Calcium Channel Blockers and Diuretics in Older Adults With Hypertension.
    Savage RD; Visentin JD; Bronskill SE; Wang X; Gruneir A; Giannakeas V; Guan J; Lam K; Luke MJ; Read SH; Stall NM; Wu W; Zhu L; Rochon PA; McCarthy LM
    JAMA Intern Med; 2020 May; 180(5):643-651. PubMed ID: 32091538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
    Kuti EL; Baker WL; White CM
    Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of physician specialty on adoption and relinquishment of calcium channel blockers and other treatments for myocardial infarction.
    Majumdar SR; Inui TS; Gurwitz JH; Gillman MW; McLaughlin TJ; Soumerai SB
    J Gen Intern Med; 2001 Jun; 16(6):351-9. PubMed ID: 11422631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
    Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS
    JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective longitudinal cohort study comparing the effects of angiotensin-converting enzyme inhibitors and long-acting calcium channel blockers on total and cardiovascular mortality in patients with hypertension.
    Tardif JC; Ducharme A; Yu H; Wogen J; Guertin MC
    Clin Ther; 2004 Jul; 26(7):1073-83. PubMed ID: 15336472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The case for beta-blockers as first-line antihypertensive therapy.
    Cruickshank JM
    J Hypertens Suppl; 1992 Jun; 10(3):S21-7. PubMed ID: 1353111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.